mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
6e-05 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
8e-05 |
mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |